PTSD

As interest in psychedelic medicine grows, researchers are increasingly turning to natural substances like ayahuasca to explore their potential in treating mental health disorders. A recent review by researchers at the University of São Paulo sheds light on how ayahuasca – a traditional...

Kendis Gibson, a familiar face in U.S. TV news, is sharing a deeply personal journey in his new book, “Five Trips.” As Variety reported, the memoir offers readers an unflinching look at Gibson's career struggles, mental health battles and his path to healing through psychedelic...

Veterans Affairs (VA) has announced a $1.5 million grant to study MDMA-assisted therapy for veterans with PTSD and alcohol use disorder, marking the first VA-funded psychedelic research in over 50 years. In January 2024, the VA first revealed plans to fund studies on the use of psychedelic...

At this year’s Telluride Film Festival, the documentary In Waves and War made its much-anticipated premiere, shedding light on the transformative power of psychedelic-assisted therapy for veterans struggling with PTSD, traumatic brain injuries (TBI) and depression. Directed by Jon Shenk and...

Legislative progress on providing veterans with access to psychedelic therapies like psilocybin, found in magic mushrooms, hit a roadblock last week as Virginia lawmakers decided not to advance a bill aimed at expanding mental health treatments for veterans. As Henrico Citizen reported, the bill,...

After years of regulatory delays, the U.S. Food and Drug Administration (FDA) has approved Phase 2 of a clinical trial to assess the efficacy of smoked medical cannabis in treating post-traumatic stress disorder (PTSD) among military veterans. Funded by Michigan's Veteran Marijuana Research Grant...

Federal agencies recently convened in a pivotal public meeting, hosted by the Reagan-Udall Foundation for the U.S. Food and Drug Administration (FDA), to discuss emerging treatments for post-traumatic stress disorder (PTSD), with a focus on the potential of psychedelics. As Lexology reported, the...

The global psychedelic drugs market is set for rapid expansion, with projections forecasting growth from $4.88 billion in 2023 to $10.2 billion by 2028, according to The Business Research Company. With a compound annual growth rate of 16.1%, this rise is largely driven by increased awareness of...

The Department of Veterans Affairs (VA) is signaling potential support for another pivotal Phase III clinical trial of psychedelic therapy to treat post-traumatic stress disorder (PTSD). As Politico reported, Dr. Shereef Elnahal, the undersecretary for health at the VA, revealed that the agency is...

In the winter of 2023, combat medic Ihor Kholodylo faced a life-altering event on Ukraine’s eastern front. A shell from a Russian tank struck his medical evacuation van, leaving him severely injured. Though Kholodylo survived, the psychological toll was profound. Despite healing from physical...

A retired Navy veteran from Covington, Georgia, is facing an uncertain legal situation in Dubai after being arrested for possessing medically prescribed CBD pills. Charles Wimberly, 52, was detained at a Dubai airport on September 27 when officials discovered the pills during a security check as...

Less than a month after the FDA rejected MDMA for PTSD treatment, and days after the agency set a September meeting to discuss psychedelic and other treatments for PTSD, the Multidisciplinary Association for Psychedelic Studies (MAPS) awarded a $200,000 grant to Emory University researchers for a...

The U.S. Food and Drug Administration (FDA) has scheduled a public meeting for September 6, 2024, to gather input on potential new treatments for post-traumatic stress disorder (PTSD), including the use of psychedelic drugs. This meeting marks a significant step in the ongoing exploration of...

A groundbreaking study published in Scientific Reports offers the most comprehensive analysis yet of how classic psychedelics, such as LSD and psilocybin, and the drug MDMA (commonly known as ecstasy) impact cognitive functions during and after use. As PsyPost reported, the research reveals that...

The recent rejection by the Food and Drug Administration (FDA) of an application that would have authorized the use of MDMA for the treatment of post-traumatic stress disorder (PTSD) reignited the already ongoing discussion on psychedelic-assisted therapies. This not only affects the 13 million...